PREDICTIVE VALUE OF CIRCULATING ENDOTHELIAL CELL (CEC) LEVELS IN METASTATIC OR LOCALLY ADVANCED NEUROENDOCRINE DIGESTIVE TUMOR PATIENTS TREATED WITH CHEMOTHERAPY AND BEVACIZUMAB

被引：0
|
作者：
Farace, F. F. [1 ]
Lombard-Bohas, C. [2 ]
Mitry, E. [3 ]
Ychou, M. [4 ]
Bengrine-Lefevre, L. [5 ]
Lecomte, T. [6 ]
Joly, K. [7 ]
Ducreux, M. [8 ]
Baudin, E.
机构：
[1] Inst Gustave Roussy, Lab Translat Res, Villejuif, France
[2] Hosp Civils Lyon, Hop Edouard Herriot, Lyon, France
[3] Inst Curie, Paris, France
[4] Ctr Val dAurelle, Montpellier, France
[5] Hop St Antoine, F-75571 Paris, France
[6] Hop Trousseau, Tours, France
[7] Roche Biomed Labs, Boulogne Billancourt, France
[8] Inst Cancerol Gustave Roussy, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：85 / 85
页数：1
相关论文
共 50 条
  • [1] Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab
    Malka, D.
    Boige, V.
    Jacques, N.
    Vimond, N.
    Adenis, A.
    Boucher, E.
    Pierga, J. Y.
    Conroy, T.
    Chauffert, B.
    Francois, E.
    Guichard, P.
    Galais, M. P.
    Cvitkovic, F.
    Ducreux, M.
    Farace, F.
    ANNALS OF ONCOLOGY, 2012, 23 (04) : 919 - U5
  • [2] Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy
    Bidard, F. -C.
    Mathiot, C.
    Degeorges, A.
    Etienne-Grimaldi, M. -C.
    Delva, R.
    Pivot, X.
    Veyret, C.
    Bergougnoux, L.
    de Cremoux, P.
    Milano, G.
    Pierga, J. -Y.
    ANNALS OF ONCOLOGY, 2010, 21 (09) : 1765 - 1771
  • [3] Circulating endothelial cell (CEC) and tumor cell (CTC) analysis in patients (pts) receiving bevacizumab and erlotinib for metastatic breast cancer (MBC)
    Rugo, HS
    Dickler, MN
    Scott, JH
    Moore, DH
    Park, JW
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S142 - S143
  • [4] Prognostic and predictive value of circulating tumor cells in metastatic breast cancer patients treated with endocrine or chemotherapy
    Ellis, MJ
    Miller, MC
    Cristofanilli, M
    Budd, GT
    Stopeck, A
    Hayes, DF
    Doyle, GV
    Matera, J
    Terstappen, LWMM
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S7 - S7
  • [5] The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab
    Simkens, L. H. J.
    Tol, J.
    Terstappen, L. W. M. M.
    Teerenstra, S.
    Punt, C. J. A.
    Nagtegaal, I. D.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2447 - 2448
  • [6] Circulating endothelial cells (CEC) and angiogenic proteins monitoring in patients (pts) with advanced hepatocellular carcinoma (HCC) treated with bevacizumab
    Boige, V.
    Baey, C.
    Dromain, C.
    Ducreux, M.
    Malka, D.
    Pignon, J.
    Farace, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Circulating endothelial cells (CEC) and angiogenic proteins monitoring in patients (pts) with advanced hepatocellular carcinoma (HCC) treated with bevacizumab
    Boige, Valerie
    Lafoix, Cecile
    Horn, Sarah
    Pignon, Jean-Pierre
    Dromain, Clarisse
    Francoise, Farace
    CANCER RESEARCH, 2009, 69
  • [8] Predictive Value of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer Patients Treated by Bevacizumab-Based Therapy.
    Mego, M.
    De Giorgi, U.
    Hsu, L.
    Dawood, S.
    Andreoupolou, E.
    Valero, V.
    Handy, B. C.
    Ueno, N. T.
    Reuben, J. M.
    Cristofanilli, M.
    CANCER RESEARCH, 2009, 69 (24) : 650S - 650S
  • [9] Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab
    Sastre, Javier
    Vidaurreta, Marta
    Gomez, Auxiliadora
    Rivera, Fernando
    Massuti, Bartomeu
    Reboredo Lopez, Margarita
    Abad, Albert
    Gallen, Manuel
    Benavides, Manuel
    Aranda, Enrique
    Diaz Rubio, Eduardo
    CLINICAL COLORECTAL CANCER, 2013, 12 (04) : 280 - 286
  • [10] Predictive value of circulating tumor cells in patients with metastatic breast cancer treated with chemotherapy or hormonotherapy:: preliminary results.
    Minchella, I
    Sandri, M. T.
    Medici, M.
    Zorzino, L.
    Botteri, E.
    Adamoli, L.
    Franceschelli, L.
    Magni, E.
    Verri, E.
    Cossu Rocca, M.
    Colleoni, M.
    Goldhirsch, A.
    Nole, F.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S137 - S137
12345